Effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP), cyperquat (MPP+) and paraquat on isolated mitochondria from rat striatum, cortex and liver

This publication has 32 references indexed in Scilit:

• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
  Published by Elsevier ,2004
• Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium
  Journal of Neurochemistry, 1986
• Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+
  Biochemical and Biophysical Research Communications, 1986
• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
  Nature, 1984
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
  Nature, 1984
• Pargyline Prevents MPTP-Induced Parkinsonism in Primates
  Science, 1984
• 1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra
  Neuroscience Letters, 1984
• Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
  Science, 1984
• Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey
  Brain Research, 1984
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983